An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile

被引:64
作者
He, L [1 ]
Wang, GL [1 ]
Zhang, Q [1 ]
机构
[1] Peking Univ, Dept Pharmaceut, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
关键词
paclitaxel; microemulsion; taxol; cremophor EL; hypersensitivity; phamacokinetics;
D O I
10.1016/S0378-5173(02)00478-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Based on the clinical fact that paclitaxel injection (Taxol(R)) frequently causes hypersensitivity reactions, we prepared an alternative paclitaxel microemulsion with small particle size (17.2 nm). The hypersensitivity evaluation and pharmacokinetic behavior in rats were conducted to assess the new microemulsion. The results showed that the new microemulsion was negative and the placebo Taxol(R) solution was positive with regard to allergic reactions. In the pharmacokinetic study, five rats were administrated Taxol(R) or paclitaxel microemulsion. Blood samples were collected at 0, 0.25, 0.5, 1, 2, 4, 6, 8, 10, 12, 14 h and paclitaxel determined by HPLC. The area under the curve (AUC) was significantly higher in the microemulsion group (34.98 mug ml(-1) h) than that in the Taxol(R) group (21.98 mug ml(-1) h). Also, the K-10 was much smaller in the microemulsion group (0.57 h(-1)) compared with the Taxol(R) group (1.29 h(-1)), showing the elimination rate was much slower in the former than in the latter. Compared with Taxol(R), the paclitaxel microemulsion caused less toxicity and had a longer circulation time in rats. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 7 条
  • [1] FENG L, 1995, PHARM RES, V12, P1060
  • [2] Lu B., 1998, NEW TECHNIQUES NEW D, P59
  • [3] PAHALA S, 1998, PDA J PHARM SCI TECH, V52, P170
  • [4] Pharmaceutical aspects of paclitaxel
    Panchagnula, R
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 172 (1-2) : 1 - 15
  • [5] TAXOL - A NOVEL INVESTIGATIONAL ANTIMICROTUBULE AGENT
    ROWINSKY, EK
    CAZENAVE, LA
    DONEHOWER, RC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15): : 1247 - 1259
  • [6] WEI XH, 2001, CHINESE J PHARM, V32, P188
  • [7] Zhang Z.-Q., 2001, CHINESE J PHARM, V32, P139